Lijekovi - lijek generičkog naziva pembrolizumab
TED · 641355-2026Award noticeawardedNo deadline given
Value
Estimated€10,838,052 · 10,838,052 EUR
Awarded€6,010,524 · 6,010,524 EUR
WinnerMEDIKA, d.d.
Who already wins at this buyer
Firms with recorded awards from Klinički bolnički centar Zagreb in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MEDIKA, d.d. | 7 | €8,773,973 | 2026-10-13 |
| ROCHE d.o.o. | 5 | €1,519,117 | 2026-09-22 |
| MEDICAL INTERTRADE d.o.o. | 3 | €2,386,017 | 2026-09-23 |
| JASIKA d.o.o. | 3 | €494,990 | 2026-09-23 |
| KEFO d.o.o. | MEDICAL INTERTRADE d.o.o. | BIOMEDICA DIJAGNOSTIKA d.o.o. | ROCHE d.o.o. | BIOVIT d.o.o. | GOREA PLUS d.o.o. | JASIKA d.o.o. | BIOSISTEMI d.o.o. | 2 | €1,885,337 | 2026-08-17 |
Full buyer profile: what Klinički bolnički centar Zagreb buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Lijekovi - lijek generičkog naziva pembrolizumab
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-10-13 | Lijekovi- lijek generičkog naziva nivolumab | Klinički bolnički centar Zagreb HR | 96% |
| 2026-09-17 | Lijekovi - lijek generičkog naziva givinostat | Klinički bolnički centar Zagreb HR | 95% |
| 2026-09-17 | Lijekovi - lijek generičkog naziva zanubrutinib | Klinički bolnički centar Zagreb HR | 95% |
| 2026-09-17 | Lijekovi-lijek generičkog naziva omaveloksolon | Klinički bolnički centar Zagreb HR | 94% |
| 2026-09-09 | Lijekovi gentamicin, valsartan+ hidroklorotiazid, klozapin, pembrolizumab - iznimna žurnost | Klinički bolnički centar Rijeka HR | 92% |
| 2026-09-16 | Lijek PEMBROLIZUMAB S.C. s liste posebno skupih lijekova za potrebe KBC-a Sestre milosrdnice | Klinički bolnički centar Sestre milosrdnice HR | 92% |